Patents
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
05/2000
05/17/2000CN1052490C Method for increasing alpha to beta ratio in L-aspartyl-L-phenylalanine coupling reaction
05/16/2000US6063917 Cephalosporin synthesis
05/16/2000US6063900 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof
05/16/2000US6063795 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/16/2000US6063794 Selective factor Xa inhibitors
05/16/2000US6063361 Administering to a patient at least one cascade polymer complex and subjecting the patient to a radiology diagnosis
05/11/2000WO2000026360A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000WO2000026252A1 Compounds with growth hormone releasing properties
05/11/2000WO2000026235A1 Method for preparing crystal of aspartame derivative excellent in stability
05/11/2000WO2000026234A1 Crystallization processes for the formation of stable crystals of aspartame derivative
05/11/2000WO2000026188A1 Cycloheximide derivatives which influence the regeneration of neural tissue
05/11/2000WO2000012539A8 Peptide compounds
05/11/2000WO2000008015A3 Fsh mimetics for the treatment of infertility
05/11/2000CA2349158A1 Compounds and methods for modulating claudin-mediated functions
05/11/2000CA2348162A1 Method for preparing crystal of aspartame derivative excellent in stability
05/11/2000CA2348021A1 Crystallization processes for the formation of stable crystals of aspartame derivative
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
05/10/2000EP0999220A2 Low molecular weight peptidomimetic growth hormone secretagogues
05/10/2000EP0998488A1 Polyol-amino acid compounds having anti-helicobacter pylori activity
05/10/2000EP0998470A1 Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000CN1252806A Dolastatin-15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
05/10/2000CN1252728A Dolastatin-15 derivatives in combination with taxanes
05/10/2000CN1052240C Method for preparing inhibitor of retroinfection viral protease
05/09/2000US6060586 Ureins derived from alpha, omega-diamono acids and process for their preparation
05/09/2000US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/09/2000US6060462 Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
05/09/2000US6060455 Cationic and polycationic amphiphiles, reactives containing the same and their use
05/09/2000US6060452 Angiogenesis inhibitors; immunomodulators
05/09/2000US6060071 Ectoin and ectoin derivatives as moisturizers in cosmetics
05/09/2000US6060065 Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission
05/09/2000CA2153584C Cytokine restraining agents
05/04/2000WO2000024923A1 The enzyme-mediated synthesis of peptidomimetics
05/04/2000WO2000024763A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000WO2000024510A1 Combinatorial approach to chiral reagents or catalysts having amine or amino alcohol ligands
05/04/2000WO2000008047A8 Depsipeptide derivatives bearing piperazinone rings
05/04/2000WO2000005263A3 Compounds for use in the treatment of inflammation
05/04/2000WO2000004868A3 Libraries of polyhydroxamates and their analogs
05/04/2000WO1999053021A9 Cell differentiation/proliferation and maintenance factor and uses thereof
05/04/2000CA2347911A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/03/2000EP0997474A1 Antithrombotic agents
05/03/2000EP0997459A1 Intermediates for preparing retroviral protease inhibiting compounds
05/03/2000EP0997147A1 Amino acid derivatives
05/03/2000EP0721465B1 Glutathione s-transferase-activated compounds
05/03/2000EP0691985B1 Phosphonomethyldipeptides
05/03/2000EP0560947B1 Trivalent monospecific antigen binding proteins
05/03/2000EP0383803B1 Oligonucleotide-polyamide conjugates
05/03/2000CN1251838A Samatotropin releasing peptide
05/02/2000US6057450 Derivatives of pyroglutaminic acid preparation process and applications
05/02/2000US6057425 Solid phase synthesis of peptides where prior to cleavage and deprotection, the protected resin peptide is reswelled with dichloromethane
05/02/2000US6057362 Protease inhibitors
05/02/2000US6057347 Comprising nonsteroidal antiinflammatory drug and compound that donates, transfers, or releases nitric oxide, elevates endogenous synthesis levels of nitric oxide, or is substrate for nitric oxide synthase
05/02/2000US6057311 Benzodiazonine derivatives binding to cholecystokinin or gastrin receptors
05/02/2000US6057297 Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
05/02/2000US6057296 Plant growth factor
05/02/2000US6057295 Oligopeptides derived from C-reactive protein fragments
05/02/2000CA2224616C Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
05/02/2000CA2022740C Cyclic neurokinin a antagonists
04/2000
04/27/2000WO2000023476A1 Neovascular-specific peptides
04/27/2000WO2000023421A1 (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
04/27/2000CA2622786A1 Neovascular-specific peptides
04/27/2000CA2347792A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
04/27/2000CA2347136A1 Neovascular-specific peptides
04/26/2000EP0995761A2 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
04/26/2000EP0995757A2 Bivalent inhibitors of the proteasome
04/26/2000EP0995756A2 Mechanism oriented inhibitors of dipeptidyl peptidase I
04/26/2000EP0995755A1 Prodrugs of Thrombin inhibitors
04/26/2000EP0994897A1 Mu-opiate receptor peptides
04/26/2000EP0994896A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4
04/26/2000EP0994895A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4
04/26/2000EP0994894A1 SELECTIVE FACTOR Xa INHIBITORS
04/26/2000EP0994893A1 Selective factor xa inhibitors containing a fused azepinone structure
04/26/2000EP0994892A1 SELECTIVE FACTOR Xa INHIBITORS
04/26/2000EP0994724A1 Methods and compositions for impairing multiplication of hiv-1
04/26/2000EP0873417A4 Compositions for the detection of proteases in biological samples and methods of use thereof
04/26/2000EP0680469B1 Aminoacid derivates, medicaments containing these compounds and process for preparing the same
04/26/2000CN1251296A Use of anticancer material and production method of said anti-cancer material
04/25/2000US6054593 Elastase inhibitor
04/25/2000US6054265 Screening assays for compounds that inhibit membrane fusion-associated events
04/21/2000CA2286971A1 A method for the purification of natural phosphorylated peptides, a mixture of phosphopeptides thus obtained and the use thereof
04/20/2000WO2000022129A1 Non-endogenous, constitutively activated human g protein-coupled receptors
04/20/2000WO2000022112A1 Stabilized bioactive peptides and methods of identification, synthesis and use
04/20/2000WO2000021987A2 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
04/20/2000WO2000021982A1 A process for the preparation of a thrombus imaging agent
04/20/2000WO2000021980A1 Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents
04/20/2000WO2000021979A2 Cyclic tetrapeptide and their use as histone deacetylase inhibitor
04/20/2000WO2000005245A3 Inhibitors of urokinase and blood vessel formation
04/20/2000WO1999065712A3 Glycosulfopeptides and methods of synthesis and use thereof
04/20/2000WO1999064050A9 Novel potassium channel drugs and their uses
04/20/2000WO1999061653A3 Light-mediated regional analysis of biologic material
04/20/2000CA2346943A1 Cyclic tetrapeptide compound and use thereof
04/20/2000CA2346122A1 Stabilized bioactive peptides and methods of identification, synthesis and use
04/20/2000CA2342314A1 Non-endogenous, constitutively activated human g protein-coupled receptors
04/20/2000CA2341975A1 A process for the preparation of a thrombus imaging agent
04/20/2000CA2341672A1 Chelator incorporated arg-gly-asp (rgd) mimetic synthetic disintegrins as imaging agents
04/19/2000EP0994121A2 Branched peptides in assays for antibodies
04/19/2000CN1251107A Method for preparing and purifying N-alkylated aspartame derivatives
04/18/2000US6051705 Having inhibitory activity against angiotensin i converting enzyme and neutral endpeptidase
04/18/2000US6051685 Modified tripeptide of tyrosine-d-arginine-phenylalanine or salt with amidino group at n-terminal; analgesic which acts through actions of opioid receptors; with side effect reduction for use in treating cancerous pain
04/18/2000US6051684 Contacting a composition containing amyloid precursor protein with di- or tripeptide analog causing a decrease in a-beta-peptide or an increase in alpha-s-amyloid precursor protein